Enzo Biochem, Inc. (NYSE:ENZ)

CAPS Rating: 1 out of 5

The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.


Player Avatar pchop123 (80.37) Submitted: 2/23/2013 12:28:04 PM : Underperform Start Price: $3.05 ENZ Score: +6.90

Too pricy for its value right now

Featured Broker Partners